AHP Redux Liability May Provide Two-Month Respite From Merger Offers
Executive Summary
American Home Products may have until the end of March to weigh its options before facing the prospect of hostile takeover offers.
You may also be interested in...
AHP Sale Of Cyanamid To BASF Will Re-Open Merger Possibilities
The sale of American Home Products' agricultural and crop sciences division Cyanamid will give the company a pharmaceutical profile that clears the way for a new round of merger discussions.
AHP Sale Of Cyanamid To BASF Will Re-Open Merger Possibilities
The sale of American Home Products' agricultural and crop sciences division Cyanamid will give the company a pharmaceutical profile that clears the way for a new round of merger discussions.
P&G Actonel Payment Postponed: $50 Mil. Delay Contributes To $40 Bil. Drop
The delay in the approval of Procter & Gamble's Actonel for osteoporosis contributed to the company's $38.7 bil. drop in value following the March 7 announcement that it will miss its earnings targets.